AnHorn Medicines Co., Ltd.
{{company.company_channel.channel_name}}
{{company.company_name_local}}
{{company.company_channel.channel_name}}
AnHorn Medicines Announces First Subject Dosed in AH-001 Phase I Clinical Trial in the United States 2025-03-27 00:00
1